new_0222_0402|IMRX|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0402|IMRX|Long Name|1|1|Immuneering Corp Total Current Assets (Quarterly) (USD)|Immuneering Corp Cash and Short Term Investments (Quarterly) (USD)|Immuneering Corp Inventories (Quarterly) (USD)|Immuneering Corp Net PP&E (Quarterly) (USD)|Immuneering Corp Goodwill and Intangibles (Quarterly) (USD)|Immuneering Corp Total Liabilities (Quarterly) (USD)|Immuneering Corp Total Current Liabilities (Quarterly) (USD)|Immuneering Corp Total Long Term Liabilities (Quarterly) (USD)|Immuneering Corp Total Deposits (Quarterly) (USD)|Immuneering Corp Book Value (Quarterly) (USD)|Immuneering Corp Retained Earnings (Quarterly) (USD)|Immuneering Corp Treasury Stock (Quarterly) (USD)|Immuneering Corp EV to Revenues|Immuneering Corp EV to Earnings|Immuneering Corp EV to Free Cash Flow|Immuneering Corp EV to Assets (Quarterly)|Immuneering Corp PS Ratio|Immuneering Corp PE Ratio|Immuneering Corp Price to Book Value|Immuneering Corp PEG Ratio|Immuneering Corp Debt to Equity Ratio|Immuneering Corp Dividend Yield|Immuneering Corp Shareholder Yield (TTM)|Immuneering Corp Percent of Shares Outstanding Short|Immuneering Corp Total Receivables (Quarterly) (USD)|Immuneering Corp Total Payables (Quarterly) (USD)|Immuneering Corp Total Capital Stock (Quarterly) (USD)|Immuneering Corp Return on Invested Capital|Immuneering Corp Quality Ratio Score|Immuneering Corp Momentum Score|Immuneering Corp Beta (1Y)|Immuneering Corp Sustainable Growth Rate (TTM)|Immuneering Corp Institutional Investor Ownership Percentage|Immuneering Corp Average Diluted Shares Outstanding (Quarterly)|Immuneering Corp Total Employees (Annual)|Immuneering Corp EPS Diluted (Quarterly) (USD)|Immuneering Corp Shares Outstanding|Immuneering Corp Repurchase of Capital Stock (Quarterly) (USD)|Immuneering Corp Ordinary Shares Number (Quarterly)|Immuneering Corp Payout Ratio|Immuneering Corp Quick Ratio (Quarterly)|Immuneering Corp Normalized Diluted EPS (Quarterly) (USD)|Immuneering Corp Stock Buybacks (Quarterly) (USD)|Immuneering Corp Effective Tax Rate (TTM)|Immuneering Corp Return on Equity|Immuneering Corp Net Income (TTM) (USD)|Immuneering Corp Revenue (TTM) (USD)|Immuneering Corp Dividend Per Share (Quarterly) (USD)|Immuneering Corp Revenue (Quarterly) (USD)|Immuneering Corp Gross Profit (Quarterly) (USD)|Immuneering Corp SG&A Expense (Quarterly) (USD)|Immuneering Corp Pre-Tax Income (Quarterly) (USD)|Immuneering Corp Net Income (Quarterly) (USD)|Immuneering Corp Net Interest Income (Quarterly) (USD)|Immuneering Corp Price (USD)|Immuneering Corp Total Return Price (USD)|Immuneering Corp Enterprise Value (USD)|Immuneering Corp 30-Day Average Daily Volume|Immuneering Corp 1 Year Price Returns (Daily)
new_0222_0402|IMRX|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0402|IMRX||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0402|IMRX||5|5|91|91|0|91|0|91|91|91|0|91|91|0|1.44117647059|0|1.44117647059|0|1.44117647059|0|1.44086021505|0|91|1.44117647059|0|15.4166666667|91|91|91|0|92|0|0|0|30.6666666667|91.3333333333|92|91.3333333333|20|0|91|91|91|91.3333333333|0|0|0|91|91|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44117647059|1.44117647059|1.44117647059|1.43925233645|0
new_0222_0402|IMRX||6|6|3|3|0|3|0|3|3|3|0|3|3|0|136|0|136|0|136|0|93|0|3|136|0|12|3|3|3|0|1|0|0|0|6|6|1|6|5|0|3|3|3|6|0|0|0|3|3|0|6|6|6|6|6|6|136|136|136|107|0
new_0222_0402|IMRX||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0402|IMRX|202003|202003|202003||||||||||||||||||||||||||||||||||13.5114||-0.2369||||||-0.2369|||||||0.483|0.228|0.644|-3.2007|-3.2007|0.0385|||||
new_0222_0402|IMRX|202006|202006|202006||||||||||||||||||||||||||||||||||13.5114||-0.2667||||||-0.2667|||||||0.4808|0.2438|0.629|-3.6038|-3.6042|0.0025|||||
new_0222_0402|IMRX|202009|202009|202009||||||||||||||||||||||||||||||||||13.5114||-0.3256||||||-0.3256|||||||0.6826|0.3676|0.699|-4.3993|-4.3991|0.0011|||||
new_0222_0402|IMRX|202012|202012|202012|37.7312|37.0902||0.6775||60.9045|2.2559|58.6486||-22.4814|-25.7376||||||||||0||||0.5001|1.4805|0.005|||||||13.5114||-0.4319|||23.8894|0|16.6635|-0.4319||||-17.0399|2.3115||0.6651|0.1918|1.138|-5.8361|-5.8359|0.0005|||||
new_0222_0402|IMRX|202103|202103|202103|32.1828|30.9337||0.6601||3.2822|2.7581|0.5241||29.575|-31.9673||||||||||0||||0.4924|1.3688|0.0135|||||||13.5114||-0.46|||23.8894|0|11.3941|-0.46||||-20.0688|2.5767||0.7482|0.339|1.184|-6.2297|-6.2297|0.0064|||||
new_0222_0402|IMRX|202106|202106|202106|51.4369|50.2451||0.6448||88.2279|4.832|83.3959||-35.1858|-39.955||||||||||0||||0.4951|1.4325|0.0053||2|||||23.8894|34|-0.3344|||23.8894|0|10.5009|-0.3344||||-24.4523|2.7559||0.66|0.3414|1.34|-7.9873|-7.9877|0.0033|||||
new_0222_0402|IMRX|202107|202106|202106|||||||||||||137.4382||-17.5383||102.7991|||||0||0|||||||||26.8677||||24.3894||||||||||||||||||17.59|17.59|378.7644||
new_0222_0402|IMRX|202108|202106|202106|||||||||||||208.3147||-26.5827||143.007|||||0||0.6683|||||||||43.8165||||25.5144||||||||||||||||||24.47|24.47|574.0923||
new_0222_0402|IMRX|202109|202109|202109|153.3108|149.478||0.6186||5.7488|5.2668|0.482||158.2936|-48.489||210.9916|-18.8608|-19.8587|3.2868|179.7357||4.3505||0|0|0|2.1828|0.4714|1.7952|0.0259|-87.825|1|||-87.825|70.414|18.2864|36|-0.47|25.9381||25.9381|0|28.4707|-0.47|-120.3188||-87.825|-28.5873|2.5554||0.4821|0.263|2.599|-8.5341|-8.5341|0.0174|26.55|26.55|539.1786|167823.9667|
new_0222_0402|IMRX|202110|202109|202109|||||||||||||216.5742||-20.3841||183.459||4.4406|||0||2.3716|||||||||70.584||||||||||||||||||||||27.1|27.1|553.4445|70801.0667|
new_0222_0402|IMRX|202111|202109|202109|||||||||||||171.2253||-16.1158||153.1984||3.7085|||0||2.3978|||||||||70.5169||||25.9406||||||||||||||||||22.63|22.63|437.5578|41203.9667|
new_0222_0402|IMRX|202112|202112|202112|||||||||||||105.6493||-9.9438||109.4661||2.6499|||0||4.0881|||||||||69.6493||||||||||||||||||||||16.17|16.17|269.9815|78791.7|
new_0222_0402|IMRX|202201|202112|202112|||||||||||||43.0171||-4.0488||67.6971||1.6388|||0||4.4691|||||||||69.6381||||||||||||||||||||||10|10|109.928|100051.3|
new_0222_0402|IMRX|202202|202112|202112|||||||||||||37.9415||-3.5711||64.3122||1.5568|||0|||||||||||||||||||||||||||||||||9.5|9.5|96.9577|104122.9333|